Evaluation of the Vitek 2 Korean Antimicrobial Susceptibility Testing Cards AST N056 and AST N055

다국어 초록 (Multilingual Abstract)

antimicrobial susceptibility cards for Vitek 2 system uses an adjusted antimicrobial combination that reflects Korean clinical practice and CLSI guidelines.
We evaluated the two Korean antimicrobial susceptibility testing cards for gram negative rods, AST N056 and AST N055.
Methods: The results of susceptibility tests were compared between the original and Korean cards. A number of the same antimicrobials included in the both cards were 15 in AST N041-AST N056 and 17
in AST N022-AST N055. Susceptibilities to the newly added antimicrobials, aztreonam, tobramycin, and meropenem for AST N056; and cefotaxime, levofloxacin, and minocycline for AST N055 were compared
with those obtained by disc diffusion test and, in case of discrepancy, by confirmative Etest or broth dilution method.
Results: In comparison between AST N041 and AST N056 cards, the average discrepancy rate per strain was 0.34, minor error was 88.2%, and major error
and very major error were both 5.9%. In comparison between AST N022 and AST055 cards, the average discrepancy rate per strain and very major error were
1.23 and 4.4%, respectively. The three antimicrobial agents added into AST N055 card showed highly discrepant results as a total of 49 items (44.1%) in 111 isolates were discrepant with very major error of
5.9% and major error of 2.0%.
Conclusion: AST N056 showed acceptable results in most items including the newly added antimicrobial agents. However, in the case of AST N055 card that showed a relatively high discrepancy, other indicator
antibiotics should be referred to for newly added three antimicrobials. For the antibiotics that showed a high discrepancy between the original and Korean
cards, a comparison study should be performed using the standard method and clinical isolates collected in Korea.

참고문헌 (Reference)

1 Gilbert DN, "The Stanford Guide to Antimicrobial Therapy. 33rd ed" Antimicrobial Therapy Inc 52-56, 2003

2 Jorgensen JH, "Selection criteria for an antimicrobial susceptibility testing system" 31 : 2841-2844, 1993

3 Clinical and laboratory standards institute, "Performance standards for antimicrobial susceptibility testing; Seventeenth informational supplement. CLSI Document M100-S17"

4 Pérez-Vázquez M, "Performance of the Vitek 2 system for identification and susceptibility testing of routine Enterobacteriaceae clinical isolates" 17 : 371-376, 2001

5 Washington JA, "Functions and activities of the Area Committee on Microbiology of the National Committee for Clinical Laboratory Standards" 4 : 150-155, 1991

6 Food and Drug Administration, "Federal guidelines. Review criteria for assessment of antimicrobial susceptibility testing device"

7 Joyanes P, "Evaluation of the Vitek 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples" 39 : 3247-3253, 2001

8 Ling TK, "Evaluation of Vitek 2 rapid identification and susceptibility testing system against gramnegative clinical isolates" 39 : 2964-2966, 2001